Renal Stones

Stone Formation

Stone formation generally follows urinary supersaturation, nucleation, crystal growth, aggregation, and retention. Low urine volume increases solute concentration and promotes supersaturation. Natural inhibitors such as citrate help prevent crystallization. Stone movement causes pain primarily by ureteral obstruction, pressure, distention, and smooth-muscle contraction rather than by the mere presence of a stone in the kidney (Perlman & Heung, 2019).

Major Stone Types

Stone type	Major mechanism	Urine tendency / clue	High-yield association
Calcium	Calcium oxalate/phosphate supersaturation; often hypercalciuria	Variable pH	Most common; serum calcium may be normal
Uric acid	Hyperuricosuria plus poor uric-acid solubility	Acidic urine	Gout, high purine burden
Cystine	Inherited cystinuria	Often acidic; characteristic crystals may occur	Younger patient, recurrent stones
Struvite	Urease-producing infection creates ammonium and alkaline urine	Alkaline urine	Proteus and other urease-positive infection; staghorn calculi

Obstruction and Kidney Injury

Obstruction raises hydrostatic pressure proximal to the stone and opposes filtration. A unilateral stone usually does not cause severe AKI if the opposite kidney is functioning, but bilateral obstruction, obstruction of a solitary functioning kidney, or severe baseline renal disease can produce postrenal AKI. Persistent obstruction can cause hydronephrosis and progressive renal injury (Norris, 2020; Perlman & Heung, 2019).

Infection Plus Obstruction

An obstructed urinary system cannot drain normally. When infection is present, urinary stasis can facilitate pyelonephritis, bacteremia, and sepsis. The combination of obstruction and infection is therefore much more dangerous than uncomplicated renal colic (Norris, 2020; Perlman & Heung, 2019).

Etiologic Evaluation and Recurrence Risk

Stone composition is a clue to the underlying pathophysiology. Recurrent or early-onset stones, bilateral disease, unusual stone composition, family history, gout, hypercalcemia, recurrent urinary infection, or evidence of cystinuria should prompt a more deliberate metabolic evaluation. The goal is to identify the driver of supersaturation—low urine volume, excess calcium, oxalate, uric acid or cystine, infection-related alkalinization, or loss of inhibitors such as citrate—so recurrence prevention targets the mechanism rather than the symptom alone (Norris, 2020; Perlman & Heung, 2019).

Diagnostic Approach

• Assess pain location/radiation, prior stones, family history, fluid intake, gout, recurrent UTI, and metabolic disease (Norris, 2020; Perlman & Heung, 2019).
• Use urinalysis for hematuria, pyuria, bacteriuria, urine pH, and crystals when present (Norris, 2020; Perlman & Heung, 2019).
• Assess creatinine and selected metabolic studies based on the clinical context (Norris, 2020; Perlman & Heung, 2019).
• Use imaging to define stone location, size, obstruction, and hydronephrosis (Norris, 2020; Perlman & Heung, 2019).
• Analyze recovered stones and consider metabolic urine testing in recurrent, bilateral, unusual, or early-onset disease (Norris, 2020; Perlman & Heung, 2019).

Clinical Manifestations

Ureteral stones classically produce abrupt colicky flank pain that may radiate toward the abdomen, groin, or genital region, often with nausea, vomiting, and microscopic or gross hematuria. Distal migration may produce urgency or frequency. A stone remaining in the kidney can be asymptomatic (Perlman & Heung, 2019).

Findings That Argue Against Uncomplicated Nephrolithiasis

RBC casts or heavy proteinuria suggest a glomerular source of hematuria. Persistent renal dysfunction without evidence of obstruction, marked systemic illness, or a pain pattern better explained by vascular, abdominal, pelvic, or musculoskeletal disease should broaden the differential. Hematuria alone is not specific for stones (Perlman & Heung, 2019).

Differential Diagnosis

Important alternatives include pyelonephritis, glomerulonephritis, abdominal aortic pathology, appendicitis, biliary disease, ovarian or other pelvic pathology, and musculoskeletal pain. Pyelonephritis and nephrolithiasis can coexist, particularly when an obstructing stone promotes infection (Norris, 2020; Perlman & Heung, 2019).

Treatment Principles

Management depends on stone size, location, composition, symptoms, obstruction, infection, and baseline renal function. Priorities are analgesia, maintaining appropriate hydration, facilitating passage when appropriate, treating infection, relieving clinically significant obstruction, and preventing recurrence by addressing the underlying urinary chemistry and stone composition (Perlman & Heung, 2019).

Red Flags

• Fever or sepsis with suspected urinary obstruction (Norris, 2020; Perlman & Heung, 2019).
• Anuria, bilateral obstruction, or obstruction of a solitary functioning kidney (Norris, 2020; Perlman & Heung, 2019).
• Rising creatinine, uncontrolled pain/vomiting, or progressive hydronephrosis (Norris, 2020; Perlman & Heung, 2019).
• Clinical deterioration suggesting infected obstruction rather than uncomplicated renal colic (Norris, 2020; Perlman & Heung, 2019).

High-Yield Distinctions

• Calcium stones are most common.
• Uric acid stones are favored by acidic urine.
• Cystine stones suggest an inherited transport disorder.
• Struvite stones suggest urease-producing infection and alkaline urine.
• Stone hematuria is nonglomerular and does not typically produce RBC casts.
• Infection plus obstruction is a high-risk combination.

Related YourDNP Resources

• Renal Pathophysiology Foundations
• Acute Kidney Injury
• Chronic Kidney Disease
• Glomerulonephritis

---

---

References

Norris, T. L. (2020). Porth’s essentials of pathophysiology (5th ed.). Wolters Kluwer.

Perlman, R. L., & Heung, M. (2019). Renal disease. In G. D. Hammer & S. J. McPhee (Eds.), Pathophysiology of disease: An introduction to clinical medicine (8th ed., pp. 493–518). McGraw-Hill Education.